سعر الميسارتان بلس 40/12.5 مجم 10 أقراص 2026

Elmistran Plus 40/12.5 mg tablets (telmisartan/HCTZ), 10 tablets (Sigma/Hochster).

• Treatment of hypertension, alone or with other antihypertensives; not for initial therapy (US telmisartan/HCTZ).Population: AdultsDailyMed / FDA

• Common (≥2%): upper respiratory tract infection, dizziness, sinusitis, diarrhea, fatigue, influenza-like symptoms, nausea (US telmisartan/HCTZ).International label, same formulation · DailyMed / FDA

• Hypersensitivity to any component; anuria; co-administration with aliskiren in patients with diabetes (US telmisartan/HCTZ).International label, same formulation · DailyMed / FDA

• Boxed warning: RAS-acting drugs can cause fetal injury/death; discontinue when pregnancy detected. Also hypotension in volume depletion, renal impairment, electrolyte disorders, acute myopia/angle-closure glaucoma (HCTZ) (US label).International label, same formulation · DailyMed / FDA

• Lithium; NSAIDs; dual RAS blockade; digoxin; antidiabetic drugs; bile-acid resinsMajorLithium toxicity risk; NSAIDs may blunt effect/worsen renal function; avoid dual RAS blockade; monitor digoxin; stagger resins (US label).DailyMed / FDA

• Can cause fetal harm; discontinue when pregnancy detected. Do not breastfeed during treatment (US label).International label, same formulation · DailyMed / FDA

• Telmisartan: Selective AT1 antagonist blocking angiotensin II vasoconstriction and aldosterone secretion.
• Hydrochlorothiazide: Promotes renal excretion of sodium and chloride, reducing intravascular volume.